orotic acid has been researched along with Cardiovascular Pregnancy Complications in 2 studies
Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The use of antihypertensive, metabolic (magnesium orotate) drugs, sedative and uroseptic phytotherapy, application of other nondrug measures in conditions of multidisciplinary dynamic support of the gestational period facilitated regress of clinical symptoms of EHT and EHT+CTD, favorable course of pregnancy and successful delivery." | 9.17 | [Magnesium orotate in treatment of chronic hypertension in pregnant women]. ( Gaĭsin, IR; Iskhakova, AS; Khodyrev, LA; Maksimov, NI; Shilina, LV; Valeeva, RM, 2013) |
| "Our objective was to study the urinary levels of orotic acid in normal pregnancy and in pregnancy-induced hypertension." | 7.70 | Urinary orotic acid levels in normal pregnancy and pregnancy-induced hypertension. ( Furutani, K; Ito, M; Matsubara, K; Ochi, H; Togari, H, 2000) |
| " The use of antihypertensive, metabolic (magnesium orotate) drugs, sedative and uroseptic phytotherapy, application of other nondrug measures in conditions of multidisciplinary dynamic support of the gestational period facilitated regress of clinical symptoms of EHT and EHT+CTD, favorable course of pregnancy and successful delivery." | 5.17 | [Magnesium orotate in treatment of chronic hypertension in pregnant women]. ( Gaĭsin, IR; Iskhakova, AS; Khodyrev, LA; Maksimov, NI; Shilina, LV; Valeeva, RM, 2013) |
| "Our objective was to study the urinary levels of orotic acid in normal pregnancy and in pregnancy-induced hypertension." | 3.70 | Urinary orotic acid levels in normal pregnancy and pregnancy-induced hypertension. ( Furutani, K; Ito, M; Matsubara, K; Ochi, H; Togari, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaĭsin, IR | 1 |
| Valeeva, RM | 1 |
| Maksimov, NI | 1 |
| Iskhakova, AS | 1 |
| Khodyrev, LA | 1 |
| Shilina, LV | 1 |
| Furutani, K | 1 |
| Ochi, H | 1 |
| Matsubara, K | 1 |
| Ito, M | 1 |
| Togari, H | 1 |
1 trial available for orotic acid and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
[Magnesium orotate in treatment of chronic hypertension in pregnant women].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Connective Tissue Diseases; Dietary Supplements; Dru | 2013 |
1 other study available for orotic acid and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Urinary orotic acid levels in normal pregnancy and pregnancy-induced hypertension.
Topics: Arginine; Female; Gestational Age; Humans; Hypertension; Nitric Oxide; Orotic Acid; Pregnancy; Pregn | 2000 |